Table 3.
Antimicrobial resistance most often used in treating infections with Staphylococcus aureus etiology
| Groups of drugs | Antimicrobial | % resistance in the age groups | ||
|---|---|---|---|---|
| Young Old [N = 311] |
Old-Old [N = 272] |
Longevity [N = 30] |
||
| Macrolides | Erythromycin (15 μg) | 25.2 | 26.1 | 30.0 |
| Lincosamides | Clindamycin (2 μg) | 22.4 | 22.1 | 30.0 |
| Aminoglycosides | Amikacin (30 μg) | 25.1 | 23.8 | 41.7 |
| Gentamicin (10 μg) | 18.8 | 22.2 | 33.3 | |
| Tobramycin (10 μg) | 29.4 | 32.7 | 50.0 | |
| Fluoroquinolones | Moxifloxacin (5 μg) | 23.7 | 34.5 | 48.1 |
| Ciprofloxacin (5 μg) | 20.8 | 25.2 | 52.9 | |
| Tetracycline | Tetracycline (30 μg) | 23.8 | 18.2 | 30.0 |
| Other | Trimethoprim/ Sulfamethoxazole (1.25/23.75 μg) | 17.0 | 83.3 | 81.2 |
| Linezolid (10 μg) | 0 | 0 | 0 | |